A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication.
Suffering from refractory epilepsy, the girl failed to respond to therapies and had exhausted all currently registered medications for treatment, the Ministry of Home Affairs (MHA) told The Sunday Times.
Already a subscriber? Log in
Dive deeper at $0.99/month
Want more exclusives, sharp insights into what's happening at home and abroad? Subscribe to stay informed.
ST One Digital Package - Monthly
$9.90 $0.99/month
No contract
$0.99/month for the first 3 months, $9.90/month thereafter. T&Cs apply.
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
2-week e-paper archive so you never miss out on any topic that matters to you
